Ali Bahathig

Dr. Ali Bahathig

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAli Bahathig
Ali Bahathig
MAMohammed A. Alarabi
Mohammed A. Alarabi
MAMuhammad Hamad Aldossary
Muhammad Hamad Aldossary
MAMalak A. Almutairi
Malak A. Almutairi
MAMohammed Abdullah Aljaffer
Mohammed Abdullah Aljaffer
FAFahad Alosaimi
Fahad Alosaimi
Background: Delirium is a common neuropsychiatric syndrome among hospitalized patients and has been associated with increased short- and long-term mortality. However, data on long-term outcomes and prognostic significance remain limited, particularly in Middle Eastern populations. Methods: This prospective observational cohort study was conducted at a tertiary care hospital in Riyadh, Saudi Arabia. Adult patients admitted to medical, surgical, and intensive care units (ICUs) underwent standardized clinical neuropsychiatric assessment for delirium. Five-year follow-up data were obtained from electronic health records and phone follow-up with patients/caregivers. Clinical outcomes and survival were compared between patients with and without baseline delirium. Kaplan–Meier survival analysis assessed five-year survival, and Cox regression explored the association between delirium and time-to-death adjusting for medical/psychiatric morbidity. Results: Among 278 patients, 71 (25.5%) were diagnosed with delirium during initial hospitalization. At five years, 51 patients (18.3%) had died. Patients with delirium had higher mortality (35.2% vs. 12.6%, p < 0.001), reduced five-year survival, and greater cumulative ward and ICU stays. In Cox regression including 50 deaths with complete data, delirium at initial assessment was associated with a higher hazard of death during follow-up (HR 1.93, 95% CI 1.06–3.55). Older age per year (HR 1.02, 95% CI 1.00–1.04), kidney disease (HR 2.12, 95% CI 1.20–3.75), and psychiatric disorders (HR 2.16, 95% CI 1.17–3.97) were independently associated with a higher hazard of death. Conclusions: Delirium was associated with increased five-year mortality and adverse long-term clinical outcomes. These findings support the prognostic significance of delirium in hospitalized patients.

15 April 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
ABAli Bahathig
Ali Bahathig
AAAyedh Hamdan Alghamdi
Ayedh Hamdan Alghamdi
MAMohammed Abdullah Aljaffer
Mohammed Abdullah Aljaffer
MAMohammed Alblowi
Mohammed Alblowi
MAMetib Alotaibi
Metib Alotaibi
AAAhmad H. Almadani
Ahmad H. Almadani
Background: Depression and anxiety are prevalent mental health disorders that substantially impact quality of life. The association of incretin mimetics, including glucagon-like peptide-1 (GLP-1) receptor agonists, with symptoms of depression and anxiety remain underexplored in Saudi Arabia. This study was conducted to assess the association between GLP-1 receptor agonist use and symptoms of depression and anxiety and to identify related factors. Methods: A cross-sectional study using convenience sampling was conducted among adults (≥18 years) treated with GLP-1 receptor agonists at King Khalid University Hospital (KKUH) in Riyadh, Saudi Arabia. Data were collected using a questionnaire developed by the research team, in addition to the Arabic versions of the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7). Results: A total of 235 participants were included, of whom 48.5% used GLP-1 receptor agonists for both glycemic control and weight loss. Only 31.9% had undergone psychiatric evaluation prior to initiating therapy, and 14.9% had a diagnosed psychiatric disorder. The mean anxiety score (GAD-7) was 4.82 ± 5, and the mean depression score (PHQ-9) was 6.13 ± 4.95. Multivariable analysis showed that higher odds of more severe depression were associated with using diabetes medications for weight loss in addition to diabetes treatment, a history of psychiatric disorders, and holding a bachelor’s degree. Exercising for 101–150 min per week was associated with lower odds of depression. Regarding anxiety, participants who exercised 101–150 min per week had significantly lower odds of anxiety compared with those who did not exercise, while a history of psychiatric disorders was associated with higher odds of more severe anxiety. Conclusions: This study’s findings highlight the importance of integrating both routine psychiatric screening and follow-up into diabetes and obesity management to enhance both psychological well-being and metabolic outcomes. They also reflect the benefit of physical activity for mental health, emphasizing the need to encourage exercise among individuals with diabetes or obesity.